AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
The pens will be returned to Novo Nordisk's facilities in Denmark – on the same boat that drops them off in the UK – and the plastic will be recycled into a range of items, such as chairs, lamps, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results